INHIBIKASE THERAPEUTICS INC (IKT) Institutional Ownership Changes & 13F Activity

INHIBIKASE THERAPEUTICS INC (IKT) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-3,42216,500$27,720
Q3 2024Renaissance Technologies LLCSell-90019,922$25,899
Q2 2024Renaissance Technologies LLCSell-60020,822$25,195
Q1 2024Renaissance Technologies LLCSell-3,00021,422$46
Q4 2023Renaissance Technologies LLCBuy8,30024,422$31
Q3 2023Renaissance Technologies LLCBuy3,40016,122$22
Q2 2023Renaissance Technologies LLCBuy12,72212,722$46

Frequently asked questions about IKT activity

  • Which institutional owners are buying IKT?

    Institutional owners buying IKT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in IKT activity?

    "Buy" means an investor increased their reported position in IKT compared to the prior reporting period. This reflects growing exposure to INHIBIKASE THERAPEUTICS INC (IKT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in IKT increasing?

    Institutional interest in IKT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related IKT insights